ISSN: 1859 - 2872
Evaluate TACE efficacy in patients with hepatocellular carcinoma before liver transplantation: Case series reports
Main Article Content
Keywords
Abstract
Objective: To evaluate the efficacy of transcatheter arterial chemoembolization (TACE) on computed tomography, histopathological images and AFP in patients with hepatocellular carcinoma before liver transplantation. Subject and method: Retrospective descriptive method, comparing before and after treatment HCC with TACE. Results were evaluated according to mRECIST criteria on CT images and tumor necrosis level on histopathological images. Result: The study included 8 hepatocellular carcinoma patients who were performed TACE before transplantation: Complete response rate was 12.5%, partial response rate was 77.5%, no patients had progressive disease on computed tomography images. Tumor necrosis was greater than 90% in 6 patients (75%) and between 50% and 90% in 2 patients (25%). Conclusion: TACE is initially effective in tumor response on computed tomography and histopathological images.
Article Details
References
2. Yao FY, Bass NM, Nikolai B et al (2002) Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat principle and Dropout from the waiting list. Liver Transplantation 8(10): 873-883.
3. Lesurtel M, Müllhaupt B, Pestalozzi BC, Pfammatter T, and Clavien PA (2006) Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. American Journal of Transplantation 6(11): 2644-2650.
4. Bộ Y tế (2020) Hướng dẫn chẩn đoán và điều trị ung thư biểu mô tế bào gan. Quyết định số 3129/QĐ-BYT-Ngày 17 tháng 7 năm 2020, tr. 12-13.
5. Eisenhauera EA, Therasseb P, Bogaertsc J et al (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline. Eur J Cancer 45(2): 228-247.
6. Alba E, Valls C, Dominguez J, Martinez L, Escalante E, Lladó L, Serrano T (2008) Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma on the waiting list for orthotopic liver transplantation. Amecican Journal of Roentgenology 190: 1341-1348.
7. Antoine Bouchard-Fortier, Real Lapointe et al (2011) Transcatheter arterial chemoembolization of hepatocellular carcinoma as a bridge to liver transplantation: A retrospective study. Int J Hepatol. 2011: 974514.
8. Hołówko W, Wróblewski T, Wojtaszek M, Grąt M, Kobryń K, Ziarkiewicz-Wróblewska B, Krawczyk M (2015) Transarterial chemoembolization prior to liver transplantation in patients with hepatocellular carcinoma. Ann Transplant 20: 764-768.
9. Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY (2014) Alpha-fetoprotein level > 1000ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl 20: 945-951.
10. Lao OB, Weissman J, Perkins JD (2009) Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation. Clin Transplant 23: 874-881.
Article Sidebar
